메뉴 건너뛰기




Volumn 5, Issue 3, 2015, Pages

Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: Data from ROCKET AF

(1,182)  Pokorney, Sean D a   Piccini, Jonathan P a   Stevens, Susanna R a   Patel, Manesh R a   Pieper, Karen S a   Halperin, Jonathan L c   Breithardt, Günter d   Singer, Daniel E e   Hankey, Graeme J f   Hacke, Werner g   Becker, Richard C a   Berkowitz, Scott D h   Nessel, Christopher C i   Mahaffey, Kenneth W j   Fox, Keith A A k   Califf, Robert M b   Anderson, J l   Bedwell, N l   Bilsker, M l   Bruce, G l   more..


Author keywords

Atrial fibrillation; Mortality; Rivaroxaban; Stroke; Warfarin

Indexed keywords

CREATININE; RIVAROXABAN; WARFARIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR;

EID: 85006208431     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.002197     Document Type: Article
Times cited : (143)

References (26)
  • 1
    • 0036797537 scopus 로고    scopus 로고
    • A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
    • Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113:359-364.
    • (2002) Am J Med. , vol.113 , pp. 359-364
    • Stewart, S.1    Hart, C.L.2    Hole, D.J.3    McMurray, J.J.4
  • 4
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
    • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
    • (1991) Stroke. , vol.22 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 5
    • 34347394385 scopus 로고    scopus 로고
    • Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-867.
    • (2007) Ann Intern Med. , vol.146 , pp. 857-867
    • Hart, R.G.1    Pearce, L.A.2    Aguilar, M.I.3
  • 7
    • 35148837212 scopus 로고    scopus 로고
    • Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)
    • Friberg L, Hammar N, Pettersson H, Rosenqvist M. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). Eur Heart J. 2007;28:2346-2353.
    • (2007) Eur Heart J. , vol.28 , pp. 2346-2353
    • Friberg, L.1    Hammar, N.2    Pettersson, H.3    Rosenqvist, M.4
  • 9
    • 84887589241 scopus 로고    scopus 로고
    • Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of longterm anticoagulant therapy study
    • Marijon E, Le Heuzey JY, Connolly S, Yang S, Pogue J, Brueckmann M, Eikelboom J, Themeles E, Ezekowitz M, Wallentin L, Yusuf S; RE-LY Investigators. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of longterm anticoagulant therapy study. Circulation. 2013;128:2192-2201.
    • (2013) Circulation. , vol.128 , pp. 2192-2201
    • Marijon, E.1    Le Heuzey, J.Y.2    Connolly, S.3    Yang, S.4    Pogue, J.5    Brueckmann, M.6    Eikelboom, J.7    Themeles, E.8    Ezekowitz, M.9    Wallentin, L.10    Yusuf, S.11
  • 13
    • 79959764913 scopus 로고    scopus 로고
    • Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study
    • Rocket AF Study Investigators. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study. Am Heart J. 2010;2159:340-347.e1.
    • (2010) Am Heart J. , vol.2159 , pp. 340-347.e1
    • Rocket A.F Study, Investigators.1
  • 14
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
    • (1976) Nephron. , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 17
    • 84878292470 scopus 로고    scopus 로고
    • Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study
    • Larsen TB, Rasmussen LH, Skjoth F, Due KM, Callréus T, Rosenzweig M, Lip GY. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study. J Am Coll Cardiol. 2013;61:2264-2273.
    • (2013) J Am Coll Cardiol. , vol.61 , pp. 2264-2273
    • Larsen, T.B.1    Rasmussen, L.H.2    Skjoth, F.3    Due, K.M.4    Callréus, T.5    Rosenzweig, M.6    Lip, G.Y.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.